treatment for dyslexia Sydney

Neurofeedback as a Treatment for Dyslexia

Dr Shelley Hyman

Neurofeedback training or EEG Neurotherapy targets the symptoms of dyslexia at their foundation, the brain.  Often visual, auditory, and/or executive processing deficiencies are present in those with learning disabilities, and neurofeedback directly targets these areas of brain function.

Not only can it target the primary symptoms, but also the secondary symptoms of learning disabilities including social emotional and self esteem difficulties. Neurofeedback produces long-term changes in an individual’s functioning and mental health.

By examining various regions of the brain through brain imaging, including QEEGs (brainmaps), researchers have found that structural differences in the left side of the brain are present in those with Dyslexia and can be treated with neurotherapy.

This makes sense given that the left side of the brain is primarily involved in the representation and comprehension of language. Breteler (2010) conducted research examining the improvements in children with dyslexia and specifically looked at reading and spelling.

They were able to find a significant improvement in spelling for the children that received the neurofeedback training when compared to the control group that did not receive the neurofeedback training. Also, their findings suggest that improvement in attentional processes in the brain could be partially what is contributing to the spelling improvements (Breteler, 2010).

Attention difficulties (ADD/ADHD) are common for those of all ages with various learning disabilities. Neurofeedback training has shown a high level of clinical success around the world, and is supported by a strong base of research in neuroscience.

There is a solution to help individuals with brain based disabilities like dyslexia make changes to their brain that have a lasting impact, no matter their age.


  • Breteler, M. (2010). Improvements in Spelling after QEEG-based Neurofeedback in Dyslexia: A Randomized Controlled Treatment Study. Applied Psychophysiology & Biofeedback, 35(1), 5-11.
Dr Shelley Hyman

About Dr Shelley Hyman

Senior Clinical Neuropsychologist. BSc (psychol) Hons, MClinNeuropsych, PhD (Med) MAPS CCN. Founder and director of the centre that was founded in 2006.